Atorvastatin treatment and vaccination efficacy.
Packard
René R S
RR
Division of Cardiology, Department of Medicine, Geneva University Hospital, 24 Micheli-du-Crest, 1211 Geneva, Switzerland.
Schlegel
Susanna
S
Senouf
David
D
Burger
Fabienne
F
Sigaud
Philippe
P
Perneger
Thomas
T
Siegrist
Claire-Anne
CA
Mach
François
F
D000328:Adult; D000917:Antibody Formation; D000924:Anticholesteremic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D000069059:Atorvastatin; D002784:Cholesterol / Q000097:blood; D004311:Double-Blind Method; D004347:Drug Interactions; D005260:Female; D035922:Hepatitis A Antibodies / Q000097:blood; D022362:Hepatitis A Vaccines / Q000008:administration & dosage* / Q000494:pharmacology; D006538:Heptanoic Acids / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage* / Q000494:pharmacology; D008297:Male; D011758:Pyrroles / Q000008:administration & dosage* / Q000494:pharmacology
D000924:Anticholesteremic Agents; D035922:Hepatitis A Antibodies; D022362:Hepatitis A Vaccines; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D002784:Cholesterol; D000069059:Atorvastatin